Basin Genomics is combining scientific backgrounds in genomics and oncology with startup expertise to translate genomic discoveries into advances in personalized clinical care and taking 'from-bench-to-bedside' to market.
Gypsy Basin is soon to be offering a cutting-edge test for oral cancer that provides early detection of precancerous cellular changes. By leveraging novel research, our breakthrough technology will have the ability to differentiate between grades of cancer by molecular signature in order to assist clinicians in selecting the most appropriate treatment options for their patients.
Company Details
- Founded
- -
- Address
- Gypsy Bay, New York 13035, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Keywords
- Genomics, Next Generation Sequencing (NGS), Bioinformatics, Consumer Genetics, DNA and Big Data.
- HQ
- Gypsy Bay, New York
Basin Genomics, Inc. Questions
Basin Genomics, Inc.'s website is https://www.gypsybasingenomics.com/
Basin Genomics, Inc.'s LinkedIn profile is https://www.linkedin.com/company/basin-genomics
Basin Genomics, Inc.'s industry is
Biotechnology Research
Basin Genomics, Inc.'s top competitors are
Optrascan,
Cellformatica,
Liscure Biosciences Inc.,
Ripple Street,
Cervivor, Inc.,
Recepto.ai,
Vian,
Headhunter,
Ophirx,
Norman Regional Health System.
Basin Genomics, Inc.'s categories are Biotechnology Research
Basin Genomics, Inc.'s founding year is 2018
